Cell

Zhang, D., Huang, J., Wang, F. et al. BMI1 regulates multiple myeloma-associated macrophage’s pro-myeloma functions. Cell Death Dis 12, 495 (2021). https://doi.org/10.1038/s41419-021-03748-y

Qiao, X., Ma, J., Knight, T. et al. The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML. Blood Cancer J. 11, 111 (2021). https://doi.org/10.1038/s41408-021-00502-7

Liu, Y., Zhou, Y., Huang, K-H. et al. Targeting epidermal growth factor-overexpressing triple-negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor. Cell Prolif. (2020). https://doi.org/10.1111/cpr.12858

Xu, Y., Wang, P., Li, M. et al. Natural small molecule triptonide inhibits lethal acute myeloid leukemia with FLT3-ITD mutation by targeting Hedgehog/FLT3 signaling. Biomed Pharmacother. (2021). https://doi.org/10.1016/j.biopha.2020.111054

Zhai, X., You, F., Xiang, S. et al. MUC1-Tn-targeting chimeric antigen receptor-modified Vγ9Vδ2 T cells with enhanced antigen-specific anti-tumor activity. Am J Cancer Res. (2021). PMID: 33520361

Tu, C., Du, Z., Zhang, H. et al. Endocytic pathway inhibition attenuates extracellular vesicle-induced reduction of chemosensitivity to bortezomib in multiple myeloma cells. Theranostics. (2021). https://www.thno.org/v11p2364.htm

Hu, Z., Zheng, X., Jiao, D. et al. LunX-CAR T Cells as a Targeted Therapy for Non-Small Cell Lung Cancer. Mol Ther Oncolytics. (2020). https://doi.org/10.1016/j.omto.2020.04.008

Chen, T., Ding, X., Liao, Q. et al. IL-21 arming potentiates the anti-tumor activity of an oncolytic vaccinia virus in monotherapy and combination therapy. J Immunother Cancer. (2021). http://dx.doi.org/10.1136/jitc-2020-001647

Chen, Y., Feng, J., Zhao, S. et al. Long-Term Engraftment Promotes Differentiation of Alveolar Epithelial Cells from Human Embryonic Stem Cell Derived Lung Organoids. Stem Cells Dev. (2018). https://doi.org/10.1038/s41408-021-00502-7

Zhai, T., Wang, C., Xu, Y. et al. Generation of a safe and efficacious llama single-domain antibody fragment (vHH) targeting the membrane-proximal region of 4-1BB for engineering therapeutic bispecific antibodies for cancer. J Immunother Cancer. (2021). http://dx.doi.org/10.1136/jitc-2020-002131